Boldenone Undecylenate from Moldavian Pharma
Boldenone Undecylenate by Moldavian Pharma contains boldenone undecylenate, an injectable anabolic androgenic steroid. Scientific and drug-reference sources describe boldenone as a testosterone-derived anabolic steroid, and note that the undecylenate ester creates a long-acting injectable form. Reviews also describe boldenone undecylenate as a product developed primarily for veterinary use, especially in horses, rather than as a routine human medicine.
This compound is widely known under the name Equipoise, although the active substance itself is boldenone undecylenate. In product terms, the defining facts are the active ingredient, the injectable format, and the long ester attached to the boldenone molecule. Those are the core details that identify the product directly and accurately.
Compound Profile
Boldenone is a steroid hormone with androgenic activity. DrugBank describes it as acting through the androgen receptor, which regulates gene transcription. That places Boldenone Undecylenate in the anabolic androgenic steroid category rather than in the category of standard sports supplements or general hormone-support products.
The undecylenate ester is important because it affects how long the compound remains active after injection. DrugBank lists a half-life of about 14 days for boldenone undecylenate, which is consistent with its reputation as a long-acting injectable product. This longer ester profile is one of the main reasons boldenone undecylenate is discussed differently from shorter esters such as propionate-based injectables.
Active Ingredient
Boldenone undecylenate
The active ingredient in this product is boldenone undecylenate. Boldenone itself is sometimes described as Δ1-testosterone, meaning it is structurally related to testosterone. A pharmacology review notes that boldenone is available as the undecylenate ester and has been used exclusively in veterinary medicine rather than as an approved human therapeutic in the United States.
Injectable ester form
Because boldenone undecylenate is an injectable ester, it belongs to a different product class from oral anabolic steroids. It is not a tablet-based compound. The long ester is one of the central features of the product and is part of the reason it remains well known in bodybuilding and performance-related discussions.
Why This Compound Is Well Known
Boldenone undecylenate has remained highly visible in bodybuilding discussions for years, largely because of its veterinary background, its injectable long-ester format, and its reputation as a classic anabolic steroid compound. At the same time, reliable sources are clear that its formal development and use history are rooted in veterinary medicine, not in mainstream human therapeutic practice.
Its visibility has also been reinforced by anti-doping rules. WADA includes boldenone on the Prohibited List under anabolic agents, which means it is not compatible with drug-tested sport. That is an important part of the compound’s profile and one of the reasons it continues to be widely recognized beyond ordinary supplement markets.
Long-Acting Injectable Nature
One of the main features of Boldenone Undecylenate is its extended-release injectable profile. Compared with short-ester injectable steroids, long esters are generally associated with slower release and longer persistence in the body. In practical product terms, this is one of the most important distinctions between boldenone undecylenate and faster-clearing compounds.
The long-acting nature of the undecylenate ester is also part of the reason this product is often discussed in relation to sustained anabolic steroid exposure rather than short, rapid-onset effects. That does not change the base compound, but it does change how the product is categorized and understood.
Safety and Risk Considerations
Boldenone Undecylenate belongs to a category of compounds that carries significant health considerations. Experimental studies and reviews have examined adverse effects linked to boldenone undecylenate, including findings related to reproductive toxicity, hepatorenal injury, cardiac toxicity, and neurobehavioral changes in animal models. These studies do not make it appropriate to generalize exact outcomes to every human use case, but they do reinforce that boldenone is not a harmless supplement and should not be described casually.
More broadly, reviews of anabolic androgenic steroids associate this class with cardiovascular, endocrine, reproductive, and psychiatric risks, especially in non-medical use. That broader context matters here because boldenone undecylenate is part of the same anabolic steroid category.
Regulatory and Sport Context
Boldenone undecylenate is not a standard wellness product. Sources describing the drug classify it as experimental, illicit, and veterinary-approved, and WADA lists boldenone among prohibited anabolic agents. Those two facts alone make it very different from routine sports nutrition products or over-the-counter supplements.
For tested athletes, this matters directly. For general buyers, it also matters because the legal and regulatory status of anabolic steroids can vary substantially by jurisdiction.
Summary
Boldenone Undecylenate by Moldavian Pharma contains boldenone undecylenate, a long-acting injectable anabolic androgenic steroid derived from testosterone and historically developed for veterinary use. It is best known by its active compound, its injectable undecylenate ester, and its long-standing visibility in bodybuilding and anti-doping discussions. It should be understood as a serious anabolic steroid product with important health, legal, and sporting implications, not as a standard supplement.
The product is available for sale to individuals and research institutions, laboratories, universities or chemical study circles intended to conduct research.
The product is not a food product or a dietary supplement, and is not suitable for human consumption.
If you feel unwell or experience side effects from contact with the substance, consult your doctor.
Special storage conditions:
Keep the undiluted vial of lyophilised powder in a cool, dry and dark place. After reconstitution, the substance should be stored at a temperature between 2 and 8 °C.
All of the above properties have been observed in laboratory studies not conducted on humans, and are intended for informational purposes only. None of the information contained in the descriptions is approved by the European Food Safety Authority (EFSA). This product is not a medicine, food or dietary supplement and is not suitable for human consumption. The product is classified as a chemical reagent/reference material authorised for use in the European Union and may only be used for scientific research. Other information about the product is contained in the safety data sheet, which we make available for inspection. The products are only available to institutions or individuals that are associated with research or laboratory activities.
